Mark Cuban (Brandon Wade/AP Images)

Mark Cuban jumps out of the Shark Tank and in­to gener­ic phar­ma with a plan to of­fer dirt-cheap drugs

The call for a whole­sale rewrite of drug pric­ing has tak­en on a fever pitch in re­cent years, reg­u­lar­ly be­com­ing part of pres­i­den­tial stump speech­es and con­gres­sion­al horse trad­ing. The fo­cus is usu­al­ly on high-price brand­ed meds, but now a new shark is in the wa­ter go­ing af­ter pricey gener­ics as well.

In an ef­fort to of­fer low-cost al­ter­na­tives to pricey gener­ic med­i­cines, bil­lion­aire in­vestor Mark Cuban has put his name to a new com­pa­ny dubbed Mark Cuban Cost Plus Drugs — an on-the-nose moniker for sure, but one with the se­ri­ous am­bi­tion of un­der­cut­ting the mar­ket on tar­get­ed meds.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA